Clinical relevance of terminal Schwann cells: An overlooked component of the neuromuscular junction
The terminal Schwann cell (tSC), a type of nonmyelinating Schwann cell, is a significant yet relatively understudied component of the neuromuscular junction. In addition to reviewing the role tSCs play on formation, maintenance, and remodeling of the synapse, we review studies that implicate tSCs in...
Saved in:
Published in | Journal of neuroscience research Vol. 96; no. 7; pp. 1125 - 1135 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.07.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The terminal Schwann cell (tSC), a type of nonmyelinating Schwann cell, is a significant yet relatively understudied component of the neuromuscular junction. In addition to reviewing the role tSCs play on formation, maintenance, and remodeling of the synapse, we review studies that implicate tSCs in neuromuscular diseases including spinal muscular atrophy, Miller–Fisher syndrome, and amyotrophic lateral sclerosis, among others. We also discuss the importance of these cells on degeneration and regeneration after nerve injury. Knowledge of tSC biology may improve our understanding of disease pathogenesis and help us identify new and innovative therapeutic strategies for the many patients who suffer from neuromuscular disorders and nerve injuries. |
---|---|
Bibliography: | Supported by the Plastic Surgery Foundation and the NIH National Institute of Neurological Disorders and Stroke Awards: F32NS098561 (to K.B.S.) and K08NS096232 (to A.K.S.W.) Funding Information Terminal Schwann cells (tSCs) are nonmyelinating Schwann cells that reside at the neuromuscular junction and are important for synaptic development, maintenance, and remodeling. In addition to their roles in degeneration and regeneration after nerve injury, tSCs have been implicated in neuromuscular diseases, including spinal muscular atrophy, Miller–Fisher syndrome, and amyotrophic lateral sclerosis. An improved understanding of tSCs may lead to novel therapeutic strategies for these neuromuscular diseases and for nerve injuries. Significance ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-2 |
ISSN: | 0360-4012 1097-4547 |
DOI: | 10.1002/jnr.24231 |